{"id":"https://openalex.org/W2004411083","doi":"https://doi.org/10.1097/00008571-200403000-00002","title":"The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients","display_name":"The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients","publication_year":2004,"publication_date":"2004-02-24","ids":{"openalex":"https://openalex.org/W2004411083","doi":"https://doi.org/10.1097/00008571-200403000-00002","mag":"2004411083","pmid":"https://pubmed.ncbi.nlm.nih.gov/15167702"},"language":"en","primary_location":{"id":"doi:10.1097/00008571-200403000-00002","doi":"https://doi.org/10.1097/00008571-200403000-00002","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00008571-200403000-00002","pdf_url":null,"source":{"id":"https://openalex.org/S196130971","display_name":"Pharmacogenetics","issn_l":"0960-314X","issn":["0960-314X","1473-561X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacogenetics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051216300","display_name":"Vincent Haufroid","orcid":"https://orcid.org/0000-0001-5040-9806","observed_orcids":["https://orcid.org/0000-0001-5040-9806"]},"institutions":[{"id":"https://openalex.org/I1315288073","display_name":"Cliniques Universitaires Saint-Luc","ror":"https://ror.org/03s4khd80","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I1315288073"]},{"id":"https://openalex.org/I95674353","display_name":"UCLouvain","ror":"https://ror.org/02495e989","country_code":"BE","type":"education","lineage":["https://openalex.org/I95674353"]},{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":true,"raw_author_name":"Vincent Haufroid","raw_affiliation_strings":["Industrial and Environmental Toxicology Unit, Kidney and Pancreas Transplantation Unit, Clinical Chemistry Department, Universit\u00e9 catholique de Louvain, St Luc Hospital, Brussels, Belgium. haufroid@toxi.ucl.ac.be","Clinical Chemistry Department, Universit\u00e9 catholique de Louvain, St Luc Hospital, Brussels, Belgium","Industrial and Environmental Toxicology Unit","e-mail: [email\u00a0protected]","fax: +32 2 764 32 28","requests for reprints to Vincent Haufroid, Industrial and Environmental Toxicology Unit, Universit\u00e9 catholique de Louvain, Clos Chapelle-aux-Champs 30/54, B-1200 Brussels, Belgium. Tel: +32 2 764 35 36"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Industrial and Environmental Toxicology Unit, Kidney and Pancreas Transplantation Unit, Clinical Chemistry Department, Universit\u00e9 catholique de Louvain, St Luc Hospital, Brussels, Belgium. haufroid@toxi.ucl.ac.be","institution_ids":["https://openalex.org/I1315288073","https://openalex.org/I95674353"]},{"raw_affiliation_string":"Clinical Chemistry Department, Universit\u00e9 catholique de Louvain, St Luc Hospital, Brussels, Belgium","institution_ids":["https://openalex.org/I95674353"]},{"raw_affiliation_string":"Industrial and Environmental Toxicology Unit","institution_ids":[]},{"raw_affiliation_string":"e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"fax: +32 2 764 32 28","institution_ids":[]},{"raw_affiliation_string":"requests for reprints to Vincent Haufroid, Industrial and Environmental Toxicology Unit, Universit\u00e9 catholique de Louvain, Clos Chapelle-aux-Champs 30/54, B-1200 Brussels, Belgium. Tel: +32 2 764 35 36","institution_ids":["https://openalex.org/I95674353","https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031616871","display_name":"Michel Mourad","orcid":"https://orcid.org/0000-0002-0372-275X","observed_orcids":["https://orcid.org/0000-0002-0372-275X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michel Mourad","raw_affiliation_strings":["Kidney and Pancreas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kidney and Pancreas","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087313579","display_name":"Val\u00e9rie Van Kerckhove","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Val??rie Van Kerckhove","raw_affiliation_strings":["Industrial and Environmental Toxicology Unit"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Industrial and Environmental Toxicology Unit","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051570194","display_name":"Wawrzyniak J\u00e9r\u00e9mie","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeremie Wawrzyniak","raw_affiliation_strings":["Industrial and Environmental Toxicology Unit"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Industrial and Environmental Toxicology Unit","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080521587","display_name":"Martine De Meyer","orcid":"https://orcid.org/0000-0003-2002-6163","observed_orcids":["https://orcid.org/0000-0003-2002-6163"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Martine De Meyer","raw_affiliation_strings":["Kidney and Pancreas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kidney and Pancreas","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049204096","display_name":"Djamila Cha\u00efb Eddour","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Djamila Chaib Eddour","raw_affiliation_strings":["Kidney and Pancreas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kidney and Pancreas","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110268543","display_name":"Jacques Malaise","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jacques Malaise","raw_affiliation_strings":["Kidney and Pancreas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kidney and Pancreas","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064346970","display_name":"Dominique Lison","orcid":"https://orcid.org/0000-0001-6557-2518","observed_orcids":["https://orcid.org/0000-0001-6557-2518"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dominique Lison","raw_affiliation_strings":["Industrial and Environmental Toxicology Unit"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Industrial and Environmental Toxicology Unit","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107847472","display_name":"Jean\u2010Paul Squifflet","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jean-Paul Squifflet","raw_affiliation_strings":["Kidney and Pancreas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kidney and Pancreas","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111494873","display_name":"Pierre E. Wallemacq","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I95674353","display_name":"UCLouvain","ror":"https://ror.org/02495e989","country_code":"BE","type":"education","lineage":["https://openalex.org/I95674353"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Pierre Wallemacq","raw_affiliation_strings":["Clinical Chemistry Department, Universit\u00e9 catholique de Louvain, St Luc Hospital, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Chemistry Department, Universit\u00e9 catholique de Louvain, St Luc Hospital, Brussels, Belgium","institution_ids":["https://openalex.org/I95674353"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5051216300"],"corresponding_institution_ids":["https://openalex.org/I1315288073","https://openalex.org/I95674353","https://openalex.org/I99464096"],"apc_list":null,"apc_paid":null,"fwci":20.6943,"has_fulltext":false,"cited_by_count":452,"citation_normalized_percentile":{"value":0.99868816,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"14","issue":"3","first_page":"147","last_page":"154"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.8988999724388123,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.8988999724388123,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10373","display_name":"Renal Transplantation Outcomes and Treatments","score":0.09549999982118607,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cyclosporine","display_name":"cyclosporine","score":0.921999990940094},{"id":"https://openalex.org/keywords/tacrolimus","display_name":"tacrolimus","score":1.0},{"id":"https://openalex.org/keywords/cyp3a5-polymorphism","display_name":"CYP3A5 polymorphism","score":0.8980000019073486},{"id":"https://openalex.org/keywords/kidney-transplantation","display_name":"kidney transplantation","score":0.8040000200271606},{"id":"https://openalex.org/keywords/immunosuppressive-drugs","display_name":"immunosuppressants","score":0.7850000262260437},{"id":"https://openalex.org/keywords/dose-requirement","display_name":"dose requirement","score":0.7250000238418579},{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.8629999756813049},{"id":"https://openalex.org/keywords/cyp3a5-3","display_name":"CYP3A5*3","score":0.8460000157356262},{"id":"https://openalex.org/keywords/c1236t","display_name":"C1236T","score":0.6729999780654907},{"id":"https://openalex.org/keywords/g2677t-a","display_name":"G2677T/A","score":0.9660000205039978},{"id":"https://openalex.org/keywords/c3435t","display_name":"C3435T","score":0.9520000219345093}],"concepts":[{"id":"https://openalex.org/C2909675724","wikidata":"https://www.wikidata.org/wiki/Q411648","display_name":"Tacrolimus","level":3,"score":0.9080188274383545},{"id":"https://openalex.org/C92137452","wikidata":"https://www.wikidata.org/wiki/Q17912018","display_name":"CYP3A5","level":4,"score":0.8375871777534485},{"id":"https://openalex.org/C31785415","wikidata":"https://www.wikidata.org/wiki/Q7846541","display_name":"Trough level","level":4,"score":0.6103870272636414},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.581214189529419},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5713878273963928},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.5692160129547119},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5656558275222778},{"id":"https://openalex.org/C2910800852","wikidata":"https://www.wikidata.org/wiki/Q7846541","display_name":"Trough Concentration","level":3,"score":0.49469897150993347},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4673745036125183},{"id":"https://openalex.org/C2779528694","wikidata":"https://www.wikidata.org/wiki/Q367700","display_name":"Ciclosporin","level":3,"score":0.46607065200805664},{"id":"https://openalex.org/C19831878","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Therapeutic index","level":3,"score":0.46251073479652405},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4579249322414398},{"id":"https://openalex.org/C2780272996","wikidata":"https://www.wikidata.org/wiki/Q1261151","display_name":"Therapeutic drug monitoring","level":3,"score":0.43806153535842896},{"id":"https://openalex.org/C128057223","wikidata":"https://www.wikidata.org/wiki/Q420566","display_name":"Calcineurin","level":3,"score":0.4323519468307495},{"id":"https://openalex.org/C2780303639","wikidata":"https://www.wikidata.org/wiki/Q740909","display_name":"Kidney transplantation","level":3,"score":0.429951936006546},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.34614837169647217},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3152536153793335},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.15682914853096008},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D003577","descriptor_name":"Cytochrome P-450 Enzyme System","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005838","descriptor_name":"Genotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011110","descriptor_name":"Polymorphism, Genetic","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016030","descriptor_name":"Kidney Transplantation","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D016559","descriptor_name":"Tacrolimus","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016559","descriptor_name":"Tacrolimus","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D016572","descriptor_name":"Cyclosporine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016572","descriptor_name":"Cyclosporine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D018432","descriptor_name":"Drug Resistance, Multiple","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D027425","descriptor_name":"ATP-Binding Cassette, Sub-Family C Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D051544","descriptor_name":"Cytochrome P-450 CYP3A","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1097/00008571-200403000-00002","doi":"https://doi.org/10.1097/00008571-200403000-00002","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00008571-200403000-00002","pdf_url":null,"source":{"id":"https://openalex.org/S196130971","display_name":"Pharmacogenetics","issn_l":"0960-314X","issn":["0960-314X","1473-561X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacogenetics","raw_type":"journal-article"},{"id":"pmid:15167702","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15167702","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacogenetics","raw_type":"Comparative Study"},{"id":"pmh:oai:dial.uclouvain.be:boreal:9859","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2078.1/9859","pdf_url":null,"source":{"id":"https://openalex.org/S4306400166","display_name":"Digital Access to Libraries","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2800384882","host_organization_name":"Harris County Public Library","host_organization_lineage":["https://openalex.org/I2800384882"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmacogenetics, Vol. 14, no. 3, p. 147-54 (2004)","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W1558311166","https://openalex.org/W1565203547","https://openalex.org/W1872591512","https://openalex.org/W1912531397","https://openalex.org/W1925047823","https://openalex.org/W1954785414","https://openalex.org/W1975261946","https://openalex.org/W1998181395","https://openalex.org/W1999502217","https://openalex.org/W2022153036","https://openalex.org/W2024131514","https://openalex.org/W2027774666","https://openalex.org/W2050497622","https://openalex.org/W2054458932","https://openalex.org/W2056362627","https://openalex.org/W2056897801","https://openalex.org/W2083650072","https://openalex.org/W2086478906","https://openalex.org/W2090971729","https://openalex.org/W2091509247","https://openalex.org/W2105902511","https://openalex.org/W2109083028","https://openalex.org/W2117005785","https://openalex.org/W2118342649","https://openalex.org/W2126262050","https://openalex.org/W2138748407","https://openalex.org/W2358501499","https://openalex.org/W2791969457"],"related_works":["https://openalex.org/W1996420787","https://openalex.org/W2038803245","https://openalex.org/W2088250393","https://openalex.org/W2977550013","https://openalex.org/W1986782670","https://openalex.org/W2388817780","https://openalex.org/W1964698840","https://openalex.org/W2553275856","https://openalex.org/W2986190728","https://openalex.org/W2116081055"],"abstract_inverted_index":{"Cyclosporine":[0],"and":[1,34,58,64,68,94,96,100,134,141,153,194,239],"tacrolimus":[2,65,86,152,217],"are":[3,12],"immunosuppressive":[4,269],"drugs":[5,253],"largely":[6],"used":[7],"in":[8,19,72,144,148,211,214],"renal":[9,77],"transplantation.":[10],"They":[11],"characterized":[13],"by":[14],"a":[15,23,265],"wide":[16],"inter-individual":[17],"variability":[18,210],"their":[20,27],"pharmacokinetics":[21],"with":[22],"potential":[24],"impact":[25],"on":[26,62],"therapeutic":[28],"efficacy":[29],"or":[30,85,191],"induced":[31],"toxicity.":[32],"CYP3A5":[33,57,133,255],"P-glycoprotein":[35],"appear":[36],"as":[37,111,113],"important":[38],"determinants":[39],"of":[40,43,48,56,159,208,222,243,268],"the":[41,54,157,161,209,220,235,241],"metabolism":[42],"these":[44],"drugs.":[45],"The":[46],"objective":[47],"this":[49,244],"study":[50],"was":[51,163,185],"to":[52,119,129,206,216,264],"investigate":[53],"effect":[55],"MDR1":[59,97,195],"(ABCB1)":[60],"polymorphisms":[61],"cyclosporine":[63,81],"dose":[66,192,212],"requirements":[67],"trough":[69,103,137,173,188],"blood":[70,104,122,189,226],"concentrations":[71,123,138,174,190,227],"stable":[73],"transplant":[74,78],"patients.":[75,179],"Stable":[76],"recipients":[79],"receiving":[80],"(n":[82,87],"=":[83,88],"50)":[84,89],"were":[90,124,139],"genotyped":[91],"for":[92,132,151],"CYP3A5*3":[93],"*6,":[95],"C1236T,":[98],"G2677T/A":[99],"C3435T.":[101],"Dose-adjusted":[102,136],"levels":[105],"(ng/ml":[106],"per":[107],"mg/kg":[108],"body":[109,116],"weight)":[110,117],"well":[112],"doses":[114],"(mg/kg":[115],"required":[118],"achieve":[120],"target":[121,225],"compared":[125],"among":[126],"patients":[127,146,150,170],"according":[128],"allelic":[130],"status":[131],"MDR1.":[135],"three-fold":[140],"1.6-fold":[142],"higher":[143],"CYP3A5*3/*3":[145,178],"than":[147,177],"CYP3A5*1/*3":[149,202],"cyclosporine,":[154],"respectively.":[155],"In":[156],"case":[158],"tacrolimus,":[160],"difference":[162],"even":[164],"more":[165],"striking":[166],"when":[167],"considering":[168],"CYP3A5*1/*1":[169],"showing":[171],"dose-adjusted":[172],"5.8-fold":[175],"lower":[176],"For":[180],"both":[181],"drugs,":[182],"no":[183],"association":[184],"found":[186],"between":[187],"requirement":[193,213],"genotype.":[196],"Multiple":[197],"regression":[198],"analyses":[199],"showed":[200],"that":[201],"polymorphism":[203],"explained":[204],"up":[205],"45%":[207],"relation":[215],"use.":[218],"Given":[219],"importance":[221],"rapidly":[223],"achieving":[224],"after":[228],"transplantation,":[229],"further":[230],"prospective":[231],"studies":[232],"should":[233],"consider":[234],"immediate":[236],"post-graft":[237],"period":[238],"assess":[240],"influence":[242],"specific":[245],"polymorphism.":[246],"Beside":[247],"non-genetic":[248],"factors":[249],"(e.g.":[250],"steroids":[251],"dosing,":[252],"interactions),":[254],"pharmacogenetic":[256],"testing":[257],"performed":[258],"just":[259],"before":[260],"transplantation":[261],"could":[262],"contribute":[263],"better":[266],"individualization":[267],"therapy.":[270]},"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":11},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":11},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":12},{"year":2020,"cited_by_count":18},{"year":2019,"cited_by_count":16},{"year":2018,"cited_by_count":16},{"year":2017,"cited_by_count":18},{"year":2016,"cited_by_count":19},{"year":2015,"cited_by_count":18},{"year":2014,"cited_by_count":12},{"year":2013,"cited_by_count":30},{"year":2012,"cited_by_count":27}],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2016-06-24T00:00:00"}